Premium
Comparison of vascular effects of ropivacaine and lidocaine on isolated rings of human arteries
Author(s) -
Gherardini G.,
Samuelson U.,
Jernbeck J.,
ÅBerg B.,
Sjöstrand N.
Publication year - 1995
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1995.tb04167.x
Subject(s) - ropivacaine , medicine , lidocaine , vasoconstriction , contraction (grammar) , isometric exercise , local anesthetic , anesthesia , vasodilation
Ropivacaine is a new local anaesthetic agent. Previous animal studies have indicated that vasoconstrictor effects are elicited by ropivacaine in vitro and subcutaneously and that it produces blanching of the skin if injected subcutaneously in humans. Lidocaine is a widely used local anaesthetic reported to exert a biphasic effect on the microvasculature with contraction at low concentrations and relaxation at high concentrations. There is a need for pharmacologic tools able to counteract local arterial vasoconstriction. In this study, the contractile effect of ropivacaine and lidocaine were investigated in vitro on isolated human arteries. Experiments were performed on 43 internal mammary artery (IMA) rings obtained from 22 patients and on 14 radial artery (RA) rings from 7 patients. The rings were mounted in organ baths and isometric contractile activity was measured. Experiments were conducted by cumulative adding ropivacaine or lidocaine (1.5X10 ‐5 M; 4.5X10 ‐5 M; 1.5X10 ‐4 M; 4.5X10 ‐4 M; 1.5X10 ‐3 M; 4.5X10 ‐3 M; 1.5X10 ‐2 M) to the organ baths. The endothelium was mechanically removed in 19 IMA rings and in 9 RA rings. Ropivacaine and lidocaine produced a biphasic response with contraction at low concentrations (1.5X10 ‐5 1.5X10 ‐3 M) and release of the maximal contraction at higher concentrations. No statistically significant differences in contractile or relaxing effects were seen between the two drugs. Removal of the endothelium did not significantly affect contractile activity. In this study of human mammary artery preparations, ropivacaine is not a stronger vasoconstrictor than lidocaine.